View All Podcasts

The Rare Air of Elevation Oncology: Raising Nearly $200M in 2 Years, with CEO Shawn Leland

October 14, 2021

Elevation Oncology has raised nearly $200M since its launch just two years ago. $200 million! That sounds like an enormous amount of investment capital, but when the company is potentially changing cancer treatment as we know it - you can see why investors are excited about Elevation's potential. Today, founder and CEO Shawn Leland tells us all about the raises, challenges and excitement of growing his company.

Sign Up For Updates